R&D News | pharmaphorum

News

Blood sample with respiratory coronavirus positive

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi

News

Male Doctor In Office Working At Computer

Payments from UK pharma to healthcare professionals increase...

The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.

News

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Pfizer and BioNTech have announced early results from their ongoing phase 1 /2 study of a potential COVID-19 coronavirus vaccine, showing the jab seems to be working in a small sample of pa

News

Bharat Biotech begins trial of COVID-19 vaccine in India as ...

Bharat Biotech is to begin trials of a coronavirus vaccine in India as the country faces a rapidly growing outbreak.

News

Intercept CEO lays into FDA after NASH drug rejection

Intercept Pharmaceuticals has accused the FDA of moving the goalposts during its review of a potential blockbuster drug for the fatty liver disease known as NASH following a rejection.

News

Trial starts with Imperial College London coronavirus vaccin...

The first healthy volunteer has been dosed with Imperial College London’s coronavirus vaccine, the second UK-developed candidate to reach the clinical testing stage.

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 tria...

Payments from UK pharma to healthcare professionals increase...

Pfizer/BioNTech's COVID-19 vaccine neutralises virus in earl...

Bharat Biotech begins trial of COVID-19 vaccine in India as ...

Intercept CEO lays into FDA after NASH drug rejection

Trial starts with Imperial College London coronavirus vaccin...

Lilly inflates US facility investment spending by $4.5bn

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks